Renasant Bank’s GSK GSK Stock Holding History

Renasant Bank’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-5,202	Closed	-$213K	–	175
2024 Q3	$213K	Hold	5,202	–	–	0.14%	160
2024 Q2	$200K	Sell	5,202 -774	-13%	-$32.6K	0.14%	159
2024 Q1	$256K	Buy	+5,976	New	+$246K	0.18%	144

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Renasant Bank's GSK Position: Q4 2024 in Review

Renasant Bank sold out of GSK (GSK) in Q4 2024, closing a stake of 5,202 shares — an estimated $213K sold.

Renasant Bank first reported a position in GSK in Q1 2024 and held it in 3 quarters. The position peaked at $256K in Q1 2024. 849 funds tracked by Wall St. Rank hold GSK as of Q4 2024.

Renasant Bank reported no remaining GSK position as of Q4 2024 after selling out during the quarter.
Renasant Bank sold 5,202 GSK shares in Q4 2024, an estimated $213K.
Renasant Bank first reported a position in GSK in Q1 2024 and held it in 3 quarters.
Renasant Bank's GSK position peaked at $256K in Q1 2024.
849 funds tracked by Wall St. Rank held GSK as of Q4 2024.

Based on Renasant Bank's 13F filing for Q4 2024, filed 10 Feb 2025.